Novo Nordisk A/S (B Shares) ADRhedged (NVOH) Dividend History

Company News

• Is Viking Therapeutics a Buy Right Now?

  Viking Therapeutics (VKTX) is a biotech company developing a weight loss drug candidate that has shown promising results in clinical trials. The company aims to launch a phase 3 trial for the injectable version of VK2735 in the second quarter. Despite recent stock declines, the article suggests that Viking could be a good buy considering the high-growth weight loss drug market opportunity and the company's progress.

  The Motley Fool

  Featured Companies: LLY VKTX